Clinical-stage biotech redefining the skin as a therapeutic vector for drug delivery.
Avro Life Science is a clinical-stage biotechnology company developing skin-based drug delivery therapies. The company positions the skin as a therapeutic vector and is advancing novel treatment approaches in this space. Specific pipeline programs and product names were not detailed on the public website at time of review. Avro Life Science is a product of Avro Life Science.